Jiangsu Hengrui Medicine will invest $240 million to build an internationally compliant biopharmaceutical production facility in its home city of Lianyungang, Jiangsu Province. The company has acquired a 200 acre site in the Lianyungang Technological Development Zone for the plant. Two months ago, Hengrui announced plans to spend $137 million building a new biologic drug manufacturing facility in Suzhou.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
